{"title": "Statement Addresses Concerns About Heart Meds and COVID-19 | Physician's Weekly", "url": " https://www.physiciansweekly.com/statement-addresses-concerns-about-heart-meds-and-covid-19/", "content": "Based on this hypothesis, the authors suggest that patients with cardiac diseases, hypertension, or diabetes, treated with ACE2-increasing drugs, may be at higher risk for severe COVID-19 infection and should be monitored for ACE2-modulating medications. \u201cThere are no experimental or clinical data demonstrating beneficial or adverse outcomes among COVID-19 patients using ACE inhibitor or ARB medications,\u201d Richard J. Kovacs, M. D. , president of the ACC, said in a statement.", "color": "group2-yellow.jpg", "warning": ""}